FDA unveils risk-management program for ESAs

被引:1
|
作者
Traynor, Kate
机构
关键词
D O I
10.2146/news100025
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:508 / 509
页数:2
相关论文
共 50 条
  • [1] FDA quietly ends a major risk-management program
    Traynor, Kate
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (11) : 761 - 761
  • [2] FDA embraces risk-management approach
    Fox, JL
    [J]. NATURE BIOTECHNOLOGY, 2003, 21 (10) : 1120 - 1121
  • [3] FDA embraces risk-management approach
    Jeffrey L. Fox
    [J]. Nature Biotechnology, 2003, 21 : 1120 - 1121
  • [4] Evaluation of the dofetilide risk-management program
    LaPointe, NMA
    Chen, A
    Hammill, B
    DeLong, E
    Kramer, JM
    Califf, RM
    [J]. AMERICAN HEART JOURNAL, 2003, 146 (05) : 894 - 901
  • [5] FDA report calls for new risk-management framework
    不详
    [J]. CHEMICAL & ENGINEERING NEWS, 1999, 77 (20) : 35 - 35
  • [6] Practitioner acceptance of the dofetilide risk-management program
    LaPointe, NMA
    Kramer, JM
    Weinfurt, KP
    Califf, RM
    [J]. PHARMACOTHERAPY, 2002, 22 (08): : 1041 - 1046
  • [7] Pessimism as risk-management
    Leahy, RL
    [J]. COGNITIVE PSYCHOTHERAPY TOWARD A NEW MILLENNIUM: SCIENTIFIC FOUNDATIONS AND CLINICAL PRACTICE, 2002, : 259 - 265
  • [8] Risk-management syndrome
    Tanaka, Masaaki
    Watanabe, Yasuyoshi
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2012, 16 (04) : 312 - 315
  • [9] Risk-management in incubators
    Ruping, K
    von Zedtwitz, M
    [J]. MANAGEMENT OF TECHNOLOGY: GROWTH THROUGH BUSINESS INNOVATION AND ENTREPRENEURSHIP, 2003, : 65 - 78
  • [10] Integrated Risk-Management Matrices
    Ince, Nathanael
    [J]. CHEMICAL ENGINEERING, 2016, 123 (05) : 65 - 69